Tonix Pharmaceuticals Holding Corporation (TNXP)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 3.99M | 3.78M | 2.48M | 2.21M | 2.82M |
営業利益 | -32.73M | -33.9M | -29M | -28.15M | -27.33M | -21.35M | -77.32M | -15.55M |
税引前収入 | -31.68M | -33.01M | -28.36M | -27.98M | -27.32M | -14.94M | -78.78M | -14.21M |
純利益 | -34.08M | -33.01M | -28.36M | -27.98M | -27.32M | -14.94M | -78.78M | -14.21M |
優先配当 | -2.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -32.73M | -33.9M | -29M | -28.15M | -25.61M | -21.94M | -77.92M | -14.21M |
EBITDA | -31.89M | -33.01M | -28.08M | -26.93M | -26.07M | -20.14M | -17.15M | -15.04M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.77M |
営業利益 | -38.97M | -21.29M | -26.32M | -28.83M | -50.51M | -92.31M | -112.09M | -118.38M |
税引前収入 | -38.84M | -21.12M | -26.09M | -28.62M | -50.46M | -92.29M | -110.22M | -116.66M |
純利益 | -38.84M | -21.12M | -29.36M | -31.09M | -52.17M | -92.29M | -116.88M | -116.66M |
優先配当 | 0 | 0 | -3.27M | -2.47M | -1.26M | 0 | -6.66M | 0 |
基本的1株当たり利益 (EPS) | -0.991 | -2.698 | -8.999 | -3.644 | -0.253 | -0.186 | -1.208 | -4.345 |
EBIT | -38.97M | -21.29M | -26.32M | -28.83M | -50.51M | -92.31M | -112.09M | -116.66M |
EBITDA | -38.84M | -21.22M | -26.27M | -28.8M | -50.48M | -92.26M | -110.84M | -114.09M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約